(Q48770270)

English

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study

scientific article published on August 1, 1983

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study (English)

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Adaptive radiation therapy

0 references

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

author name string

D. F. Nelson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347995

4 October 2023

D. Schoenfeld

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347995

4 October 2023

A. S. Weinstein

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347995

4 October 2023

J. S. Nelson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347995

4 October 2023

T. Wasserman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347995

4 October 2023

R. L. Goodman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347995

4 October 2023

S. Carabell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347995

4 October 2023

language of work or name

0 references

publication date

1 August 1983

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

full work available at URL

https://api.elsevier.com/content/article/PII:0360301683901724?httpAccept=text/xml

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

https://api.elsevier.com/content/article/PII:0360301683901724?httpAccept=text/plain

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

9

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

1143-1151

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers

1

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Distribution of misonidazole in human tumours and normal tissues

2

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

4

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Misonidazole and radiotherapy to treat malignant glioma: A phase II trial of the radiation therapy oncology group

5

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Hyperbaric oxygen and radiation therapy in the management of glioblastoma

6

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Is tumour radiosensitization by misonidazole a general phenomenon?

8

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses

9

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Nonparametric Estimation from Incomplete Observations

11

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

A Phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas

14

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas

17

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Controlled study of CCNU and radiation therapy in malignant astrocytoma

18

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme

19

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

20

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity.

21

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

22

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

23

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone

24

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Clinical trials of misonidazole in the United States

25

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Radiation Therapy Oncology Group clinical trials with misonidazole

26

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Phenytoin sodium-induced alterations in the pharmacokinetics of misonidazole in the dog

27

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice

28

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity

29

1 reference

10.1016/0360-3016(83)90172-4

https://api.crossref.org/works/10.1016/0360-3016(83)90172-4

4 October 2023

Identifiers

10.1016/0360-3016(83)90172-4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/6347995

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48770270&oldid=1986511867"